Antares Pharma, Inc.: 10-Q filed 2014-08-07
What Antares Pharma, Inc. reported in its quarterly report filed 2014-08-07 (fiscal Q2 2014): 34 published measures, 90 facts as tagged in accession 0001193125-14-300641.
This filing
- Form
- 10-Q (quarterly report)
- Filed
- 2014-08-07
- Fiscal period
- fiscal Q2 2014
- Accession
- 0001193125-14-300641 on SEC EDGAR
Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All Antares Pharma, Inc. filings.
Reported measures
Total assets
Resources recognized on the balance sheet. Book assets are not the market value of the business.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-06-30 | 82,725,625 | USD | |
| At 2013-12-31 | 88,931,931 | USD |
Total liabilities
Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-06-30 | 27,289,393 | USD | |
| At 2013-12-31 | 18,218,203 | USD |
Stockholders equity
The reported residual interest after liabilities. It is an accounting amount, not market capitalization.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-06-30 | 55,436,232 | USD | |
| At 2013-12-31 | 70,713,728 | USD |
Cash and cash equivalents
Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-06-30 | 41,017,975 | USD | |
| At 2013-12-31 | 39,067,236 | USD | |
| At 2013-06-30 | 35,914,972 | USD | |
| At 2012-12-31 | 52,097,064 | USD |
Net income or loss
Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-04-01 to 2014-06-30 | -9,097,725 | USD | 91 |
| 2014-01-01 to 2014-06-30 | -17,892,330 | USD | 181 |
| 2013-04-01 to 2013-06-30 | -5,103,256 | USD | 91 |
| 2013-01-01 to 2013-06-30 | -8,511,704 | USD | 181 |
Capital expenditure payments
Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-01-01 to 2014-06-30 | 918,337 | USD | 181 |
| 2013-01-01 to 2013-06-30 | 1,807,732 | USD | 181 |
Revenue
Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-04-01 to 2014-06-30 | 6,326,785 | USD | 91 |
| 2014-01-01 to 2014-06-30 | 11,528,980 | USD | 181 |
| 2013-04-01 to 2013-06-30 | 5,837,544 | USD | 91 |
| 2013-01-01 to 2013-06-30 | 10,365,766 | USD | 181 |
Retained earnings or deficit
Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-06-30 | -191,188,271 | USD | |
| At 2013-12-31 | -173,295,941 | USD |
Net property, plant and equipment
Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-06-30 | 8,613,160 | USD | |
| At 2013-12-31 | 6,952,251 | USD |
Share-based compensation expense
Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-01-01 to 2014-06-30 | 1,203,596 | USD | 181 |
| 2013-01-01 to 2013-06-30 | 882,598 | USD | 181 |
Operating income or loss
Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-04-01 to 2014-06-30 | -9,091,153 | USD | 91 |
| 2014-01-01 to 2014-06-30 | -17,899,497 | USD | 181 |
| 2013-04-01 to 2013-06-30 | -5,130,670 | USD | 91 |
| 2013-01-01 to 2013-06-30 | -8,533,959 | USD | 181 |
Current assets
Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-06-30 | 69,515,554 | USD | |
| At 2013-12-31 | 72,659,535 | USD |
Current liabilities
Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-06-30 | 22,187,282 | USD | |
| At 2013-12-31 | 16,363,007 | USD |
Current accounts payable
Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-06-30 | 6,461,140 | USD | |
| At 2013-12-31 | 6,378,712 | USD |
Goodwill carrying amount
Recognized goodwill remaining after accumulated impairment. It arises from business combinations and does not measure the current value of the company’s brand.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-06-30 | 1,095,355 | USD | |
| At 2013-12-31 | 1,095,355 | USD |
Net finite-lived intangible assets
Finite-lived intangible assets after amortization. This excludes goodwill and should not be combined with indefinite-lived intangible assets without checking scope.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-06-30 | 2,630,112 | USD | |
| At 2013-12-31 | 1,345,177 | USD |
Net current accounts receivable
Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-06-30 | 3,065,166 | USD | |
| At 2013-12-31 | 1,034,492 | USD |
Operating expenses
Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-04-01 to 2014-06-30 | 13,287,858 | USD | 91 |
| 2014-01-01 to 2014-06-30 | 26,121,652 | USD | 181 |
| 2013-04-01 to 2013-06-30 | 7,487,532 | USD | 91 |
| 2013-01-01 to 2013-06-30 | 13,391,900 | USD | 181 |
Net inventory
Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-06-30 | 8,334,688 | USD | |
| At 2013-12-31 | 6,461,051 | USD |
Gross profit
Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-04-01 to 2014-06-30 | 4,196,705 | USD | 91 |
| 2014-01-01 to 2014-06-30 | 8,222,155 | USD | 181 |
| 2013-04-01 to 2013-06-30 | 2,356,862 | USD | 91 |
| 2013-01-01 to 2013-06-30 | 4,857,941 | USD | 181 |
Cost of revenue
Costs attributed to goods produced and sold and services provided during the period. This is not the sum of every operating expense.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-04-01 to 2014-06-30 | 2,130,080 | USD | 91 |
| 2014-01-01 to 2014-06-30 | 3,306,825 | USD | 181 |
| 2013-04-01 to 2013-06-30 | 3,480,682 | USD | 91 |
| 2013-01-01 to 2013-06-30 | 5,507,825 | USD | 181 |
Research and development expense
Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-04-01 to 2014-06-30 | 3,942,948 | USD | 91 |
| 2014-01-01 to 2014-06-30 | 8,476,574 | USD | 181 |
| 2013-04-01 to 2013-06-30 | 4,395,528 | USD | 91 |
| 2013-01-01 to 2013-06-30 | 7,468,213 | USD | 181 |
Common shares outstanding
Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-06-30 | 130,300,648 | shares | |
| At 2013-12-31 | 128,740,604 | shares |
Accumulated other comprehensive income or loss
Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-06-30 | -653,292 | USD | |
| At 2013-12-31 | -653,202 | USD |
Other noncurrent assets
Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-06-30 | 871,444 | USD | |
| At 2013-12-31 | 871,444 | USD |
Accrued current liabilities
Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-06-30 | 8,419,221 | USD | |
| At 2013-12-31 | 5,453,075 | USD |
Prepaid expenses and other current assets
Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-06-30 | 1,030,785 | USD | |
| At 2013-12-31 | 1,706,678 | USD |
Comprehensive income or loss
Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-04-01 to 2014-06-30 | -9,100,006 | USD | 91 |
| 2014-01-01 to 2014-06-30 | -17,892,420 | USD | 181 |
| 2013-04-01 to 2013-06-30 | -5,102,345 | USD | 91 |
| 2013-01-01 to 2013-06-30 | -8,530,148 | USD | 181 |
General and administrative expense
General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-04-01 to 2014-06-30 | 4,330,981 | USD | 91 |
| 2014-01-01 to 2014-06-30 | 7,120,947 | USD | 181 |
| 2013-04-01 to 2013-06-30 | 1,933,768 | USD | 91 |
| 2013-01-01 to 2013-06-30 | 3,884,198 | USD | 181 |
Depreciation, depletion and amortization
Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-01-01 to 2014-06-30 | 503,786 | USD | 181 |
| 2013-01-01 to 2013-06-30 | 159,735 | USD | 181 |
Other nonoperating income or expense
Other income or expense outside operations under this concept. The composition is filer-specific and can include one-time items.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-04-01 to 2014-06-30 | -6,572 | USD | 91 |
| 2014-01-01 to 2014-06-30 | 7,167 | USD | 181 |
| 2013-04-01 to 2013-06-30 | 27,414 | USD | 91 |
| 2013-01-01 to 2013-06-30 | 22,255 | USD | 181 |
Change in accounts receivable
The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-01-01 to 2014-06-30 | 2,030,674 | USD | 181 |
| 2013-01-01 to 2013-06-30 | 2,101,486 | USD | 181 |
Change in inventories
The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-01-01 to 2014-06-30 | 1,873,637 | USD | 181 |
| 2013-01-01 to 2013-06-30 | 27,741 | USD | 181 |
Change in accounts payable
The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-01-01 to 2014-06-30 | -1,083,503 | USD | 181 |
| 2013-01-01 to 2013-06-30 | 2,316,452 | USD | 181 |
Inspect the source
- Entity
- Antares Pharma, Inc. / CIK 0001016169
- Captured
- SEC response SHA-256
540b8a117c7898b4d835a42d9aec42c261c74ea0da49d4755fcc6f2d9b68be71
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001016169.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))